Drug Database
Back to search

Belgium· BE-AMP-SAM314982-00

Atripla 600 mg - 200 mg - 245 mg

A emtricitabine, tenofovir disoproxil and efavirenz product containing tenofovir disoproxil fumarate, registered in Belgium by Gilead Sciences Ireland UC. The same ATC class is registered in 13 of our 19 countries.

ATC J05AR06

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedAtripla 600 mg - 200 mg - 245 mgATCJ05AR06REGISTER NO.BE-AMP-SAM314982-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tenofovir disoproxil fumarateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Emtricitabine, tenofovir disoproxil and efavirenz is registered in 13 of 19 countries.

Countries holding a registration under ATC J05AR06 (emtricitabine, tenofovir disoproxil and efavirenz), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose
Search emtricitabine, tenofovir disoproxil and efavirenz products by name

Emtricitabine, tenofovir disoproxil and efavirenz · ATC J05AR06

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Tenofovir Disoproxil Fumarate
Manufacturer
Gilead Sciences Ireland UC
Country
Belgium (BE)
ATC code
J05AR06
ATC class
Emtricitabine, tenofovir disoproxil and efavirenz
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    2647071
  • be_apb
    0794511

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

4 interactions on record for emtricitabine, tenofovir disoproxil and efavirenz.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check emtricitabine, tenofovir disoproxil and efavirenz against other medicinesHow interaction checks work

Emtricitabine, tenofovir disoproxil and efavirenz · interactions on record

4 records

4 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Emtricitabine, tenofovir disoproxil and efavirenz in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All emtricitabine, tenofovir disoproxil and efavirenz products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Tenofovir Disoproxil Accordpharma, Tenofovir Ratiopharm
  • Bulgaria · Тенофовир Зентива, Тенофовир Полфарма
  • Cyprus · Tenoviral
  • Czechia · Tenofovir Disoproxil Accordpharma, Tenofovir Disoproxil Sandoz
  • Germany · Tenofovirdisoproxil Accord, Tenofovirdisoproxil Al
  • Denmark · Tenofovir Disoproxil Accordpharma, Tenofovir Disoproxil Glenmark
  • Estonia · Tenofovir Disoproxil Sandoz
  • Spain · Tenofovir Disoproxilo Accordpharma, Tenofovir Disoproxilo Aurovitas
  • Finland · Tenofovir Disoproxil Hexal, Tenofovir Disoproxil Sandoz
  • France · Tenofovir Disoproxil Accord, Tenofovir Disoproxil Arrow
  • United Kingdom (Northern Ireland) · Tenofovir Disoproxil, Tenofovir Disoproxil Accordpharma
  • Greece · Agardon, Tenofovir Disoproxil Accord Pharma
  • Croatia · Teynofor
  • Hungary · Tenofovir Disoproxil Accordpharma, Tenofovir Onkogen
  • Ireland · Tenofovir Disoproxil Accordpharma, Tenofovir Disoproxil Teva
  • Iceland · Tenofovir Disoproxil Viatris, Tenofovir Disoproxil Zentiva
  • Italy · Tenofovir Disoproxil Aurobindo, Tenofovir Disoproxil Doc Generici
  • Liechtenstein · Tenofovir Disoproxil Viatris, Tenofovir Disoproxil Zentiva
  • Latvia · Tenofovir Disoproxil Teva
  • Netherlands · Tenofovir Disoproxil Accord, Tenofovir Disoproxil Accordpharma
  • Norway · Filmdrasjerte Tabletter Viatris, Tenofovir Disoproxil Accordpharma
  • Poland · Tenofovir Disoproxil Accordpharma, Tenofovir Disoproxil Aurovitas
  • Portugal · Tenofovir Accord, Tenofovir Aurobindo
  • Romania · Tenofovir Disoproxil Accord, Tenofovir Disoproxil Accordpharma
  • Sweden · Tenofovir Disoproxil Accordpharma, Tenofovir Disoproxil Glenmark

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b11955c1-d67f-474d-b197-6e7df93f3449
GET /v1/drugs/b11955c1-d67f-474d-b197-6e7df93f3449?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Atripla 600 mg - 200 mg - 245 mg",
  "name_fr": "Atripla 600 mg - 200 mg - 245 mg",
  "name_nl": "Atripla 600 mg - 200 mg - 245 mg",
  "amp_code": "SAM314982-00",
  "strengths": [
    "200.0000",
    "245.0000",
    "245.0000",
    "245.0000",
    "600.0000",
    "600.0000",
    "200.0000",
    "200.0000",
    "600.0000",
    "245.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Tenofovir Disoproxil Fumarate",
    "Emtricitabine",
    "Tenofovir Disoproxil",
    "Efavirenz"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Emtricitabine, Tenofovir Disoproxil and Efavirenz",
  "authorisation_numbers": [
    "EU/1/07/430/002",
    "EU/1/07/430/001"
  ]
}
API referenceMCP serverPlans

See everything about emtricitabine, tenofovir disoproxil and efavirenz.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console